Georgia's national population-based cancer registry, run by the National Center for Disease Control and Public Health since 1 January 2015. It counts about 10,000 to 11,000 new cancers a year across the whole country.
The registry was launched on 1 January 2015 by the National Center for Disease Control and Public Health, with medical facilities treating cancer required to share information with it. Before then, IANPHI reports, routine surveillance from about 200 facilities registered only 4,200 new cancers in 2014; since 2015 more than 10,000 have been recorded each year. Notification was at first on paper; in 2019 the Center launched a unified electronic system that combines screening, diagnosis and treatment data and updates each patient's vital status from the death register. The coordinates are an approximate Tbilisi city point.
The registry's report for 2015 to 2021 gives between 10,073 and 11,380 new cancers a year including in situ tumours, 10,432 in 2021 (281.3 per 100,000), with 38.2% of cancers found at stage I or II and 38.6% at stage III or IV in 2021. A national analysis of 2015 to 2019 counted 50,098 invasive cancers other than non-melanoma skin cancer, with age-standardised rates of 175.5 per 100,000 men and 192.8 per 100,000 women; lung and prostate cancer led in men, and breast and thyroid cancer in women.
IARC's GLOBOCAN 2024 fact sheet for Georgia lists no country-specific incidence source and estimates incidence from national mortality; the registry's counts and IARC's estimate differ.
The authors call this the first comprehensive evaluation of cancer incidence in Georgia. Overall incidence was lower than IARC's 2022 estimate for the 27 EU countries, which they suggest may reflect differences in health care, screening uptake or reporting accuracy.
Curing hepatitis C does not remove liver cancer risk for people who already have cirrhosis; the authors call for routine follow-up of treated cirrhotic patients so liver cancer is found earlier.
Hepatitis C is a major driver of liver cancer in Georgia, and the authors call for closer liver cancer monitoring of people with hepatitis C.
The potential of early detection is underused in Georgia, and the large share of small thyroid cancers among early-stage cancers may reflect overdiagnosis, which the authors say needs further study.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Lung cancer (all types), Breast cancer (all types).
Shares Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia, Lung cancer (all types), Breast cancer (all types), Colorectal cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Lung cancer (all types), Breast cancer (all types).
Shares Cancer registries and population surveillance, Lung cancer (all types), Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Lung cancer (all types), Breast cancer (all types).
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, Lung cancer (all types), Breast cancer (all types), Prostate cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Thyroid cancer, Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/